bioRxiv
Satellite Bio publishes first preprint on expandable hepatocyte technology
The liver fails when its functional cells fail.
Satellite Bio's proprietary off-the-shelf liver therapy is designed to deliver functional liver cells into the body, where they engraft to boost liver function and enable the processes necessary for life.
One Cell, Two Therapeutic Strategies
Satellite Bio’s approach is built on a simple insight: restoring hepatocyte function is the most direct way to treat hepatic insufficiency – whether these powerful cells are delivered directly to the liver or ectopically.
The liver acts as the body’s metabolic plant, responsible for more than 500 vital functions, including converting toxins into harmless substances that leave the body, the processing of nutrients and the production of blood proteins. Severe liver diseases arise when the liver’s functional cells, called hepatocytes, can no longer perform these critical activities.
Satellite Bio is developing a breakthrough new approach to restore this essential cellular function and improve liver performance. Our proprietary off-the-shelf liver therapy is designed to deliver functional liver cells into the body, where they engraft to boost liver function and enable the processes necessary for life.
Our Story
We are a passionate, interdisciplinary team that collaborates deeply and thinks differently. We have a high bar for study excellence, empowered decision making and multidisciplinary teamwork. We're committed to improving lives of people impacted by severe liver diseases who currently have no effective treatment options.
By leveraging the hepatocyte's unique ability to divide and expand, similar to how the liver naturally regenerates, we can treat hepatic insufficiency using an off-the-shelf cell infusion.
The very best of science and technology come together to deliver healthy, living hepatocyte cells that can restore the function of a damaged liver.
